Advertisement

Index by author

May 01, 1992; Volume 41,Issue 5

  1. Hajian, G

    1. Membrane permeation characteristics of 5'-modified thymidine analogs.
      B A Domin, W B Mahony, G W Koszalka, D J Porter, G Hajian and T P Zimmerman
      Molecular Pharmacology May 1992, 41 (5) 950-956;

  2. Hanley, M R

    1. Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
      C S D'Santos, A Gatti, D R Poyner and M R Hanley
      Molecular Pharmacology May 1992, 41 (5) 894-899;

  3. Hartzell, H C

    1. Differences in effects of forskolin and an analog on calcium currents in cardiac myocytes suggest intra- and extracellular sites of action.
      H C Hartzell and D Budnitz
      Molecular Pharmacology May 1992, 41 (5) 880-888;

  4. Henichart, J P

    1. DNA-binding properties of a distamycin-ellipticine hybrid molecule.
      C Bailly, C O'Huigin, R Houssin, P Colson, C Houssier, C Rivalle, E Bisagni, J P Henichart and M J Waring
      Molecular Pharmacology May 1992, 41 (5) 845-855;

  5. Hodge, A S

    1. Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
      A S Hodge, D R Humphrey and T L Rosenberry
      Molecular Pharmacology May 1992, 41 (5) 937-942;

  6. Holt, B D

    1. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
      S A Green, B D Holt and S B Liggett
      Molecular Pharmacology May 1992, 41 (5) 889-893;

  7. Houssier, C

    1. DNA-binding properties of a distamycin-ellipticine hybrid molecule.
      C Bailly, C O'Huigin, R Houssin, P Colson, C Houssier, C Rivalle, E Bisagni, J P Henichart and M J Waring
      Molecular Pharmacology May 1992, 41 (5) 845-855;

  8. Houssin, R

    1. DNA-binding properties of a distamycin-ellipticine hybrid molecule.
      C Bailly, C O'Huigin, R Houssin, P Colson, C Houssier, C Rivalle, E Bisagni, J P Henichart and M J Waring
      Molecular Pharmacology May 1992, 41 (5) 845-855;

  9. Humphrey, D R

    1. Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
      A S Hodge, D R Humphrey and T L Rosenberry
      Molecular Pharmacology May 1992, 41 (5) 937-942;
Back to top

In this issue

Advertisement